NMRA Neumora Therapeutics, Inc.
Company Analysis
Latest News
🔴 Neumora Therapeutics is trading 5% down today amid broad market weakness
Neumora Therapeutics is trading 5.31% down at $0.39 on October 22, 2026, amid weakness across the broader market. - The S&P 500 was down 1.03% and the Nasdaq...
🔴 Neumora Therapeutics is trading 10% down, with no direct catalyst identified
Neumora Therapeutics is trading 10.26% lower at $0.42, with no direct catalyst identified for the October 21 decline. - XBI is up 2.10% and major indexes are...
🔴 Neumora Therapeutics is trading 6% down
Neumora Therapeutics is trading at $0.44, down 6.04%, as of 10:32 a.m. EST on October 21, 2026; no fresh company-specific announcement explaining the decline...
🟢 Neumora Therapeutics is trading 11.81% up in pre-market after XBI rose 3.64% in prior session
Neumora Therapeutics is trading at $0.52, up 11.81% before the October 21, 2026 open, with broader biotech strength the clearest context. - The XBI rose 3.64%...
🟢 Neumora Therapeutics is trading 6.06% up in pre-market amid biotech-sector strength
Neumora Therapeutics is trading at $0.49, up 6.06% in pre-market, alongside broad biotech-sector strength. - XBI was up 3.64% pre-market; no new...
🟢 Neumora Therapeutics is trading 6.4% up in after-hours trading with no company-specific cause identified
Neumora Therapeutics is trading at $0.50, up 6.38% in after-hours trading; no company-specific cause for the move was established. - The regular-session close...
🟢 Neumora Therapeutics is trading 6.25% up with no company-specific catalyst identified
Neumora Therapeutics is trading 6.25% higher at $0.50, alongside improving U.S. technology sentiment; no company-specific catalyst has been established. - The...
🟢 Neumora Therapeutics is trading 10% up in pre-market as catalyst remains unclear
Neumora Therapeutics is trading 9.75% higher at $0.52, with no clear company-specific catalyst identified for the October 19 pre-market move. - The latest...
🟢 Neumora Therapeutics is trading 5.5% up in after-hours trading
Neumora Therapeutics is trading at $0.50, up 5.53% after hours, with no clear catalyst identified. - Available news listings show no fresh company-specific...
🟢 Neumora Therapeutics is trading 10.73% up
Neumora Therapeutics is trading at $0.47, up 10.73%; the reason for the advance remains unclear. - No clear company-specific announcement or catalyst for the...
🟢 Neumora Therapeutics is trading 5.57% up
Neumora Therapeutics is trading 5.57% higher at $0.45, with no clear company-specific catalyst identified for the October 16 move. - It closed October 15 at...
🟢 Neumora Therapeutics is trading 6.5% up in pre-market
Neumora Therapeutics is trading at $0.45, up 6.46%, with no clear company-specific catalyst identified. - The provided price context shows a 20.45%...
🟢 Neumora Therapeutics is trading 5.4% up in after-hours trading
Neumora Therapeutics is trading 5.39% higher at $0.45 after hours, with no clear company-specific catalyst for the move. - Shares gained 20.45% in the regular...
🟢 Neumora Therapeutics is trading 19.38% up on October 15 with no clear catalyst
Neumora Therapeutics is trading at $0.42, up 19.38%, with no clear company-specific catalyst; biotech-sector strength may be contributing. - Biotech ETF XBI...
🟢 Neumora Therapeutics is trading 12.78% up in after-hours trading
Neumora Therapeutics is trading 12.78% up at $0.40 after-hours, with no clear company-specific catalyst identified. - The stock closed the October 14 regular...
🔴 Neumora Therapeutics is trading 10.67% down today amid broader pressure after hotter-than-expected inflation
Neumora Therapeutics is trading at $0.33, down 10.67%, as broader weakness followed hotter-than-expected inflation; no company-specific catalyst was identified...
🔴 Neumora Therapeutics is trading 5% down today as growth stocks face inflation and rate concerns
Neumora Therapeutics is trading 5.13% down at $0.35 on October 14, 2026, amid pressure on broader markets and biotech shares. Supplied market context points to...
🟢 Neumora Therapeutics is trading 8.37% up in pre-market
Neumora Therapeutics is trading 8.37% higher at $0.40 in pre-market; the reason for the move remains unclear. - Shares closed October 13 at $0.37 after falling...
🟢 Neumora Therapeutics is trading 7.75% up in after-hours trading — no clear catalyst reported
Neumora Therapeutics is trading 7.75% higher after hours at $0.40, following a regular-session close of $0.37 on October 13, 2026; no clear company-specific...
🔴 Neumora Therapeutics is trading 10.2% down
Neumora Therapeutics is trading at $0.39, down 10.15%. The available evidence does not identify a clear direct catalyst for the October 13 decline. - An...